With assistance from a high tech robot, National Institutes of Health researchers have identified and tested a molecule that shows promise as a possible treatment for the rare Gaucher disease and the more common Parkinson’s disease. Ellen Sidransky, M.D., a senior investigator with NIH’s National Human Genome Research Institute (NHGRI), and her collaborators at the National Institute of Neurological Disorders and Stroke (NINDS) and the National Center for Advancing Translational Sciences (NCATS), published their findings June 12, 2016 in the Journal of Neuroscience.
Related posts:
- Medicare Card, Scientists identify main component of brain repair after stroke Medicare Card, Scientists identify main component of brain repair after stroke...
- Medicare Card, Brain tumor invasion along blood vessels may lead to new cancer treatments Medicare Card, Brain tumor invasion along blood vessels may lead to new cancer treatments...
- Medicare Card, NIH researchers reveal link between powerful gene regulatory elements and autoimmune diseases Medicare Card, NIH researchers reveal link between powerful gene regulatory elements and autoimmune diseases...
- Medicare Card, NIH researchers use brain imaging to understand genetic link between Parkinson’s and a rare disease Medicare Card, NIH researchers use brain imaging to understand genetic link between Parkinson’s and a rare disease...
- Medicare Card, NIH launches trial for rare degenerative muscle disease treatment Medicare Card, NIH launches trial for rare degenerative muscle disease treatment...
- eMERGE network moves closer to tailored treatments based on patients’ genomic information Researchers in the Electronic Medical Records and Genomics (eMERGE) network will receive $25 million over the next four years to demonstrate that patients’ genomic information linked to disease characteristics and symptoms in their electronic medical records can be used to improve their care. The grants are from the National Human Genome Research Institute (NHGRI), part […]...
- Sequencing program focus on inherited diseases, medical applications A new funding plan by the National Human Genome Research Institute (NHGRI) sharpens the focus of its flagship Genome Sequencing Program on medical applications. In addition to continuing on-going studies, the four-year, $416 million plan launches new efforts to find causes of rare inherited diseases and accelerate the use of genome sequence information in the […]...
- Medicare Card, NIH collaboration helps advance potential Zika treatments Medicare Card, NIH collaboration helps advance potential Zika treatments...
- Medicare Card, NIH awards $40 million in grants to reduce stroke disparities in the U.S. Medicare Card, NIH awards $40 million in grants to reduce stroke disparities in the U.S....
- Medicare Card News: NIH Researchers Explore How Healthy, Young Adults View the Role Genetics Plays in Improving Health Most healthy young adults place greater emphasis on health habits than on genetic risk factors when considering what causes common diseases, a research team from the National Human Genome Research Institute (NHGRI) and the Henry Ford Health System in Detroit has found. The study, based on a survey of 25- to-45-year-olds, was released June 8, […]...
- Medicare Card, A SMARTer approach to stroke care Medicare Card, A SMARTer approach to stroke care...
- Medicare Card, Paramedics may be first line of treatment for stroke Medicare Card, Paramedics may be first line of treatment for stroke...
- Medicare Card, NIH-funded study reveals how differences in male and female brains emerge Medicare Card, NIH-funded study reveals how differences in male and female brains emerge...
- Medicare Card, Standard blood pressure target is sufficient for treating some strokes Medicare Card, Standard blood pressure target is sufficient for treating some strokes...
- Medicare Card, NIH-funded study suggests brain is hard-wired for chronic pain Medicare Card, NIH-funded study suggests brain is hard-wired for chronic pain...